Horizon Branches Out With Oncology Program
This article was originally published in Scrip
Executive Summary
Stepping away from its usual research service agreements, Horizon Discovery Group Plc. has signed an in-licensing and option agreement with French pharma company Servier Laboratories for an oncology program.